Heather has experience with drafting and prosecution, including UK, European and foreign prosecution. Heather has expertise in UK, European, Australian and New Zealand patent law and practice.
Prior to joining HGF, Heather worked for IP Australia (the Australian patent office) for over three years as a Patent Examiner. In this role, she searched and examined patents for medical devices, chemical engineering and mixed mechanical technologies. Heather was involved in several projects at IP Australia including investigating the use of artificial intelligence to support patent examination and providing subject matter expert support for the development of new systems. She also gained valuable experience as an acting Senior Examiner, leading a team of Patent Examiners in chemical engineering technologies.
Heather graduated from The University of Sydney in 2015 with a Bachelor of Biomedical Engineering (Honours) with a mechanical engineering major. Her honours research project focused on designing hydrogel models to test the effect of brain tissue rigidity on the migration of brain cancer cells. In the final year of her degree and after graduating she gained experience working with assistive technologies and respiratory devices.
Heather specialises in medical technologies including respiratory devices, orthopaedic implants, bionic implants, surgical tools, dental implants and biomaterials.
Bachelor of Biomedical Engineering (Mechanical Major) (Honours) at The University of Sydney
PG Cert Intellectual Property at Bournemouth University
Master of Intellectual Property Law at The University of Technology Sydney (Australia)
Heather joined the CIPA Informals Committee in 2021 as the Education Coordinator. She also represents student members on the CIPA Education Committee.
Heather regularly attends IP Inclusive events.
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …Event details
HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …Read article
With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.